[Frontiers in Bioscience 2, e21-27, 1997]

	[Frontiers in Bioscience 2, e21-27, 1997] Reprint PubMed CAVEAT LECTOR
	WEEKLY PACLITAXEL AS A RADIATION SENSITIZER FOR LOCALLY ADVANCED GASTRIC AND PANCREATIC CANCERS:THE BROWN UNIVERSITY ONCOLOGY GROUP EXPERIENCE William M. Sikov, MD and Howard Safran, MD Department of Medicine, The Miriam Hospital and the Brown University School of Medicine, Providence, RI Received 3/24/97 Accepted 4/3/97; On-line 5/1/97 TABLE OF CONTENTS 1. Abstract 2. Introduction 2.1. Background 2.2. Paclitaxel 2.3. Paclitaxel, radiation and the cell cycle 2.4. Paclitaxel as a radiation sensitizer in NSCLC 2.5. Paclitaxel/RT is unaffected by p53 mutations in NSCLC 3. Phase I study of paclitaxel/RT for gastric and pancreatic cancer 4. Phase II studies of neoadjuvant paclitaxel/RT in locally advanced gastric and pancreatic cancers 4.1. Preliminary results 4.2. Activity of paclitaxel/RT in pancreatic and gastric tumors with p53 mutations 5. Future directions 6. Acknowledgment 7. References 8. Entire manuscript Search OMIM (Online Mendelian Inheritance in Man) to find related articles This form requires a WWW Client such as Netscape, XMosaic, Lynx that supports fill-in forms. Enter one or more search keywords: To Search all fields, leave the following boxes unchecked. To narrow your search to certain specific fields, check the boxes next to those fields' names. SeeQuery Help for other ways to search. Title: OMIM Number: Allelic Variants: Text: References: Clinical Synopsis: Gene Map Disorder: Contributors: See only records which have been changed in the past Display at most

[Frontiers in Bioscience 2, e21-27, 1997]
Reprint
PubMed
CAVEAT LECTOR

WEEKLY PACLITAXEL AS A RADIATION SENSITIZER FOR LOCALLY ADVANCED GASTRIC AND PANCREATIC CANCERS:THE BROWN UNIVERSITY ONCOLOGY GROUP EXPERIENCE

William M. Sikov, MD and Howard Safran, MD

Department of Medicine, The Miriam Hospital and the Brown University School of Medicine, Providence, RI

Received 3/24/97 Accepted 4/3/97; On-line 5/1/97

TABLE OF CONTENTS

1. Abstract
2. Introduction: 2.1. Background; 2.2. Paclitaxel; 2.3. Paclitaxel, radiation and the cell cycle; 2.4. Paclitaxel as a radiation sensitizer in NSCLC; 2.5. Paclitaxel/RT is unaffected by p53 mutations in NSCLC
3. Phase I study of paclitaxel/RT for gastric and pancreatic cancer
4. Phase II studies of neoadjuvant paclitaxel/RT in locally advanced gastric and pancreatic cancers: 4.1. Preliminary results; 4.2. Activity of paclitaxel/RT in pancreatic and gastric tumors with p53 mutations
5. Future directions
6. Acknowledgment
7. References
8. Entire manuscript

Search OMIM (Online Mendelian Inheritance in Man) to find related articles
This form requires a WWW Client such as Netscape, XMosaic, Lynx that supports fill-in forms.